Certara GlobalSubmit eCTD software Overview
Globalsubmit provides eCTD submission software to mitigate rejection risks in a complex regulatory environment. Differences in regulatory requirements complicate the submission process.
Use Cases
Customers recommend Sending & Publishing Communications, Workflow Management, Onboarding, as the business use cases that they have been most satisfied with while using Certara GlobalSubmit eCTD software.
Business Priorities
Scale Best Practices and Launch New Products are the most popular business priorities that customers and associates have achieved using Certara GlobalSubmit eCTD software.
Certara GlobalSubmit eCTD software Use-Cases and Business Priorities: Customer Satisfaction Data
Certara GlobalSubmit eCTD software's features include Templates. and Certara GlobalSubmit eCTD software support capabilities include 24/7 Support, Email Support, Chat Support, etc. also Certara GlobalSubmit eCTD software analytics capabilities include Custom Reports, and Analytics.
Reviews
"...GlobalSubmits approach to document management is a familiar one intuitive interface, easy implementation that appeals to the novice user, built-in templates and workflows, and integration with eCTD publishing systems...." Peer review
Popular Business Setting
for Certara GlobalSubmit eCTD software
Top Industries
- Pharmaceuticals
Popular in
- Enterprise
Certara GlobalSubmit eCTD software is popular in Pharmaceuticals, and is widely used by Enterprise,
Comprehensive Insights on Certara GlobalSubmit eCTD software Use Cases
How can Certara GlobalSubmit eCTD software enhance your Sending & Publishing Communications process?
How efficiently Does Certara GlobalSubmit eCTD software manage your Workflow Management?
How does Certara GlobalSubmit eCTD software facilitate Onboarding?
What makes Certara GlobalSubmit eCTD software ideal for Content Management?
8+ more Business Use Cases
11 buyers and buying teams have used Cuspera to assess how well Certara GlobalSubmit eCTD software solved their business needs. Cuspera uses 376 insights from these buyers along with peer reviews, customer case studies, testimonials, expert blogs and vendor provided installation data to help you assess the fit for your specific business needs.
Case Studies
CASE STUDY CMC Writing Support
CASE STUDY a global biopharmaceutical company in Colombia
CASE STUDY Arvinas
CASE STUDY Medtronic
Certara GlobalSubmit eCTD software Features
- Low
- Medium
- High
FEATURE | RATINGS AND REVIEWS |
---|---|
Custom Reports | Read Reviews (48) |
Analytics | Read Reviews (1) |
CAPABILITIES | RATINGS AND REVIEWS |
---|---|
Custom Reports | Read Reviews (48) |
Analytics | Read Reviews (1) |
Software Failure Risk Guidance
?for Certara GlobalSubmit eCTD software
Overall Risk Meter
Top Failure Risks for Certara GlobalSubmit eCTD software
Certara, USA. News
Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025 - TradingView
Certara will announce its second quarter 2025 financial results on August 6th, 2025, after market close. A conference call to discuss the results will follow at 5:00 PM ET.
Certara Announces D360 Version 25.5 Release
Certara has released D360 version 25.5, enhancing data visualization and analytics for drug development. Key updates include dynamic data subsets, improved sequence-based modality support, and small molecule analysis capabilities. The release also introduces API changes, requiring a switch to Service Tokens for authentication.
Certara Announces Expansion of Clinical Technology Collaboration with Merck - TradingView
Certara has expanded its clinical technology collaboration with Merck, enhancing Merck's use of Certara's Pinnacle 21 software platform. This expansion includes a metadata repository and data standards workflow management, aiming to streamline regulatory submissions and manage data standards in clinical trials.
Certara Reports Second Quarter 2025 Financial Results
Certara reported its financial results for Q2 2025, showing a 12% revenue increase to $104.6 million. Software revenue grew by 22%, while services revenue rose by 5%. The company reduced its net loss to $2 million from $12.6 million in Q2 2024. Certara reiterated its full-year financial guidance, highlighting strong performance in biosimulation software and services.
Certara, USA. Profile
Company Name
Certara, USA.
Company Website
https://www.certara.com/HQ Location
123 South Broad Street, Suite 1850, Philadelphia, PA 19109, US
Employees
11-50
Social
Financials
PRIVATE